The investment case as a mechanism for addressing the NCD burden: Evaluating the NCD institutional context in Jamaica, and the return on investment of select interventions.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 20 10 2018
accepted: 05 09 2019
entrez: 5 10 2019
pubmed: 5 10 2019
medline: 5 10 2019
Statut: epublish

Résumé

Noncommunicable diseases (NCDs) are a broad challenge for decision-makers. NCDs account for seven out of every 10 deaths globally, with 42 percent occurring prematurely in individuals under age 70. Despite their heavy toll, NCDs are underfunded, with only around two percent of global funding dedicated to the disease set. Country governments are responsible for funding targeted actions to reduce the NCD burden, but among other priorities, many have yet to invest in the health-system interventions and policy measures that can reduce the burden. This article examines "investment cases" as a potential mechanism for catalyzing attention to-and funding for-NCDs. In Jamaica, using the UN inter-agency OneHealth Tool, we conducted an economic analysis to estimate the return-on-investment from scaling up strategic clinical interventions, and from implementing or intensifying policy measures that target NCD risk factors. In addition, we conducted an institutional and context (ICA) analysis, interviewing stakeholders across sectors to take stock of promising policy pathways (e.g., areas of general consensus, political appetite and opportunity) as well as challenges to implementation. The economic analysis found that scaling up clinical interventions that target CVD, diabetes, and mental health disorders, and policy measures that target tobacco and alcohol use, would save over 6,600 lives between 2017-2032, and avert JMD 81.3 billion (USD 640 million) in direct and indirect economic costs that result from mortality and morbidity linked to NCDs. The ICA uncovered government economic growth targets and social priorities that would be aided by increased attention to NCDs, and it linked these targets and priorities to the economic analysis.

Identifiants

pubmed: 31584979
doi: 10.1371/journal.pone.0223412
pii: PONE-D-18-26128
pmc: PMC6777795
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0223412

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : ErratumIn
Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Health Aff (Millwood). 2017 Mar 1;36(3):564-571
pubmed: 28228484
Eur J Epidemiol. 2015 May;30(5):357-95
pubmed: 25837965
J Glob Health. 2018 Jun;8(1):010301
pubmed: 29391944
J Occup Environ Med. 2003 Dec;45(12):1303-11
pubmed: 14665817
Lancet. 2017 May 20;389(10083):1981-2004
pubmed: 28433256
Lancet. 2018 May 19;391(10134):2071-2078
pubmed: 29627159
Popul Health Manag. 2011 Oct;14(5):223-30
pubmed: 21506731
Lancet Psychiatry. 2016 May;3(5):415-24
pubmed: 27083119

Auteurs

Brian Hutchinson (B)

Center for Noncommunicable Diseases, RTI International, Seattle, Washington, United States of America.

Roy Small (R)

HIV, Health and Development Group, United Nations Development Programme, New York, New York, United States of America.

Kofi Acquah (K)

Social Policy, Health and Economics Research (SPHERE), RTI International, Research Triangle Park, North Carolina, United States of America.

Rosa Sandoval (R)

Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, D.C., United States of America.

Rachel Nugent (R)

Center for Noncommunicable Diseases, RTI International, Seattle, Washington, United States of America.

Tamu Davidson (T)

Noncommunicable Diseases and Injuries Prevention, Jamaica Ministry of Health, Kingston, Jamaica

Delia Itziar Belausteguigoitia (DI)

Noncommunicable Diseases and Mental Health, Pan American Health Organization, Washington, D.C., United States of America.

Nicholas Banatvala (N)

UN Interagency Task Force on the Prevention and Control of Noncommunicable Diseases, World Health Organization, United Nations, Geneva, Switzerland.

Douglas Webb (D)

HIV, Health and Development Group, United Nations Development Programme, New York, New York, United States of America.

Dudley Tarlton (D)

Bureau Policy and Programme Support, United Nations Development Programme, New York, New York, United States of America.

Alexey Kulikov (A)

UN Interagency Task Force on the Prevention and Control of Noncommunicable Diseases, World Health Organization, United Nations, Geneva, Switzerland.

Elisa Prieto (E)

Noncommunicable Diseases and Mental Health, Caribbean Subregional Program Coordination, Pan American Health Organization, Bridgetown, Barbados.

Karin Santi (K)

HIV, Health and Development Group, United Nations Development Programme, Panama City, Panama.

Classifications MeSH